Anavex Life Sciences Corp.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -17.5 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
3.94 | 4.83 | -18.35% |
|
|
| P/FCF |
|
-21.7 | 61 | -135.58% |
|
|
| Ev/Ebitda |
|
-8.23 | -22.17 | -62.89% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-11.1 | 68.76 | -116.14% |
|
|
| E/P |
|
-0.0643 | 0.0178 | -461.77% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | 0 | 0% |
| ROE |
|
-32.81 | 9.61 | -441.38% |
|
|
| ROA |
|
-29.66 | 0.3443 | -8715.99% |
|
|
| ROIC |
|
-37.92 | 7.63 | -596.7% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-33.48 | 15.45 | -316.73% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.68 | -100% | -0.0093 | -100% |
| Nеt Debt/Ebitda |
|
2.78 | -3.44 | -180.97% |
|
|
| Debt/Ratio |
|
0 | 0.1986 | -100% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
0 | 10.32 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -57.64 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
64.46 | -90.94 | -170.88% | ||
| Growth impulse Net Income in 5 years |
|
65.39 | -97.8 | -166.86% | ||
| Growth impulse FCF in 5 years |
|
46.72 | -108.72 | -142.97% | ||
| Growth impulse EPS in 5 years |
|
14.49 | -142.05 | -110.2% |
IP Score
3.25/10
